Skip to main content
. 2020 Nov 3;9(11):2409. doi: 10.3390/cells9112409

Figure 6.

Figure 6

Recurrence-free survival stratified by (A) presence or absence of germline single-nucleotide variants (SNVs) at any site at positions +1 to +100 in the rDNA promoter region (presence versus wild type (WT)) in 82 lung adenocarcinoma (LUAC) patients, and (B) germline SNV at positions +1 to +100 in the rDNA promoter region (presence versus WT) in Stage I LUAC excluding MIA (n = 42), and (C) in Stage I/II LUAC excluding MIA (n = 60).